Category: Coronavirus
Coronavirus News
New Philippines coronavirus variant has 484K and 501Y mutations
On Thursday, the Department of Health (DoH) in Central Visayas (The Philippines) confirmed that they have detected two mutations with “potential clinical significance” of SARS-CoV-2 that cause the disease. More...
Nearly half of all mild coronavirus cases have long-covid symptoms 6 months later
Almost half of all people with mild coronavirus cases still have at least one symptom six months after recovering, a new Israeli study found. More...
Japan finds new coronavirus variant with 484K mutation in 91 patients
Japan has confirmed that a new variant of Sars-COV-2 with the E484K mutation on the spike protein has been found in 91 patients. More...
Wanted man quits coronavirus lockdown at home for ‘peace and quiet’ in prison
A wanted man handed himself in to police in West Sussex to avoid having to spend any more time in lockdown with the people he lives with. More...
New Finnish Covid variant Fin-796H variant has key coronavirus mutation 484K
The New Finnish variant Fin-796H shares with the South African variant the key mutation 484K that has been claimed to be central in the impaired vaccine protection. More...
Astrazenica coronavirus vaccine: “We did not expect 40 percent side effects”
Shortly after the vaccination with the Astra-Zeneca active ingredient, 37 out of 88 employees in a Braunschweig, Germany clinic were temporarily unable to work. More...
F-FDG brain PET hypometabolism in patients with long COVID
These metabolic clusters were highly discriminant to distinguish [long covid] patients and healthy subjects (100% correct classification). More...
Pfizer says South African variant 501Y.V2 B.1.351 could reduce vaccine protection by up to 66%
A laboratory study suggests that the South African variant of the coronavirus N501Y.V2 More...
Longer duration of acute infection with B117 variant relative to non B.1.1.7 SARS-CoV-2
“These data offer evidence that SARS-CoV-2 variant B.1.1.7 may cause longer infections with similar peak viral concentration compared to non-B.1.1.7 SARS-CoV-2. More...